 |
||||||||
|
Molecular Devices 660-665 Eskdale Road RG41 5TS Wokingham United Kingdom Contact : Mme Carlene Whitehead Tél : +44 (0) 118 944 4651 Fax : +44 (0) 118 944 8001 E-mail : carlene.whitehead@moldev.com Web : http://www.moleculardevices.com/ |
|
|||||||
Molecular Devices, fabricant de systèmes analytiques de haute technologie, commercialise instruments, logiciels et réactifs dans le domaine du Drug Discovery et de la recherche en sciences de la vie. En proposant des systèmes modulables en termes de débits, de contenus et de coûts, Molecular Devices contribue au développement de la biologie cellulaire et moléculaire dans l’industrie pharmaceutique, les biotechnologies ainsi que dans la recherche publique. Les produits Molecular Devices sont le fruit d’une expertise dans les domaines de l’ingéniérie et des sciences biologiques. La société a un long passé d’innovation qui a permis à ses clients de développer leur productivité et leur efficacité. Molecular Devices,basé en Californie dans la Silicon Valley , dispose de bureaux en Grande Bretagne, Allemagne , Corée, Chine et Japon. Molecular Devices supplies high-performance analytical systems, including instruments, software, and reagents, helping accelerate drug discovery and basic life science research. By providing systems that address just about any combination of throughput, content, and budget needs, Molecular Devices helps pharmaceutical and biotechnology as well as academic and government labs leverage advances in molecular, cellular, and systems science to understand normal and abnormal biological functions and discover and Develop and test novel therapeutics. Molecular Devices® products are based on proprietary core technologies that integrate expertise in engineering and biological sciences. The company has long history of developing innovative, first-to-market products that have enabled its customers to Improve laboratory productivity and effectiveness. Molecular Devices is based in Silicon Valley, CA, United States, and has regional offices in the United Kingdom, Germany, Korea, China, and Japan to support the global life science, drug discovery and basic-research communities. |
||||||||
